LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 68 filers reported holding LOXO ONCOLOGY INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $285,592,000 | -18.0% | 2,038,920 | 0.0% | 80.87% | +7.4% |
| Q3 2018 | $348,309,000 | -41.6% | 2,038,920 | -40.7% | 75.27% | -3.9% |
| Q2 2018 | $596,584,000 | +50.4% | 3,438,920 | 0.0% | 78.30% | +10.7% |
| Q1 2018 | $396,748,000 | +37.1% | 3,438,920 | 0.0% | 70.71% | +23.6% |
| Q4 2017 | $289,488,000 | -25.0% | 3,438,920 | -17.9% | 57.19% | -9.8% |
| Q3 2017 | $385,883,000 | +14.9% | 4,188,920 | 0.0% | 63.39% | +10.2% |
| Q2 2017 | $335,909,000 | +90.6% | 4,188,920 | 0.0% | 57.53% | +79.3% |
| Q1 2017 | $176,270,000 | +36.2% | 4,188,920 | +4.0% | 32.09% | +6.7% |
| Q4 2016 | $129,409,000 | +22.7% | 4,028,920 | 0.0% | 30.09% | +38.5% |
| Q3 2016 | $105,477,000 | +12.9% | 4,028,920 | 0.0% | 21.73% | -1.5% |
| Q2 2016 | $93,390,000 | -10.0% | 4,028,920 | +6.1% | 22.05% | +6.1% |
| Q1 2016 | $103,793,000 | -3.9% | 3,796,362 | 0.0% | 20.78% | +11.6% |
| Q4 2015 | $108,006,000 | +79.0% | 3,796,362 | +10.0% | 18.63% | +75.6% |
| Q3 2015 | $60,350,000 | -3.0% | 3,452,493 | 0.0% | 10.61% | +14.5% |
| Q2 2015 | $62,248,000 | +44.8% | 3,452,493 | 0.0% | 9.27% | +64.8% |
| Q1 2015 | $42,984,000 | +6.0% | 3,452,493 | 0.0% | 5.62% | -8.5% |
| Q4 2014 | $40,567,000 | -10.5% | 3,452,493 | 0.0% | 6.15% | -30.0% |
| Q3 2014 | $45,330,000 | – | 3,452,493 | – | 8.79% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|